-+ 0.00%
-+ 0.00%
-+ 0.00%

Futura Secures EU, UK Clearance for New Formulation of Erectile Dysfunction Treatment

MT Newswires·07/31/2026 07:13:55
Listen to the news
07:13 AM EDT, 07/31/2026 (MT Newswires) -- Futura Medical (FUM.L) said Friday its Eroxon Intense treatment for erectile dysfunction was authorized for commercial launch across the European Economic Area and in the UK. Cooper Consumer Health, Futura's regional commercial partner for Eroxon, holds the option to distribute the new formulation in the European Economic Area and the UK. The consumer healthcare company expects to obtain the US Food and Drug Administration's clearance for Eroxon Intense during the second half.